Home > > > > > Report Detail

Global Prostate Cancer Therapeutics Market to 2020

Publisher Name :
Date: 06-Nov-2015
No. of pages: 80
Inquire Before Buying

Global Prostate Cancer Therapeutics Market Overview

The prostate cancer drugs market is expected to nearly double by 2020, due to the introduction of new, more expensive drugs. Prostate Cancer is the most frequently diagnosed cancer in men. In terms of loss of life from any disease, prostate cancer ranks eleventh; and it ranks sixth in terms of cancer–related mortality in men. The prostate cancer market has a huge demand for new and novel drugs that address unmet needs such as improved survival time, less toxicity, increased progression free survival, increased effectiveness, and lower cost. The global market for the prostate cancer therapeutics market is increasing, driven primarily by the growth in the hormone–refractory prostate cancer therapeutics market. Although, the prostate cancer market faces some hindrances such as the high cost of prostate cancer drugs, the market for prostate cancer drugs is likely to rise in the future.

Global Prostate Cancer Drugs Analysis: Zytiga was the leading prostate cancer drugs in 2014 being followed by Xtandi drugs. In prostate cancer drugs market, Leuplin and Zoladex stand at the third and fourth position respectively in 2014, while Lupron stands at the fifth position in the same year. Bayer's cancer drug Xofigo is also increasing its market share. Decapeptyl, Taxotere, Jevtana and Provenge are the other popular prostate cancer drugs in the global market.

Renub Research report titled “Global Prostate Cancer Therapeutics Market to 2020” provides a comprehensive assessment of the fast–evolving, high–growth of Prostate Cancer Therapeutics Market. This 80 page report with 35 Figures and 2 Tables analyses the Prostate Cancer Therapy Drugs Market, driving factors and challenges for prostate cancer market landscape.

The report covers the following:

A. Global Prostate Cancer – Hormonal Therapy Drugs Market

I Luteinizing Hormone–Releasing Hormone (LHRH) Antagonists

1. Zytiga

2. Gonax

II Luteinizing Hormone–Releasing Hormone (LHRH) Analogs

1. Lupron

2. Zoladex

3. Decapeptyl

4. Eligard

5. Vantas

6. Leuplin

III Anti–Androgens  

1. Casodex

2. Xtandi or MDV3100

3. Xtandi US or MDV3100

B. Global Prostate Cancer Chemotherapy Drugs Market

1. Taxotere

2. Jevtana

C. Global Prostate Cancer Immunotherapy Drugs Market–

1. Provenge

D. Global Prostate Cancer Targeted Therapy Drugs Market–

1. Xofigo or Alpharadin

Global Prostate Cancer Therapeutics Market to 2020

Table of Contents

1. Executive Summary

2. Prostate Cancer – Overview
2.1 Prostate Cancer Introduction
2.2 Risk Factors
2.2.1 Age
2.2.2 Race
2.2.3 Family History/Genetics
2.2.4 Diet/Lifestyle Factors
2.2.5 Obesity
2.2.6 Infection/Inflammation of the Prostate Gland
2.3 Disease Symptoms
2.4 Diagnosis
2.4.1 Digital Rectal Exam (DRE) 
2.4.2 Prostate Specific Antigen (PSA) Blood Test
2.4.3 Prostate Ultrasound and Biopsy
2.4.4 Bone Scan
2.4.5 CT Scan & MRI
2.4.6 PET & SPECT Scan
2.4.7 Lymph Node Biopsy
2.4.8 ProstaScint Scan
2.5 Stages of Prostate Cancer
2.5.1 Stage I
2.5.2 Stage II
2.5.3 Stage III
2.5.4 Stage IV

3. Global Prostate Cancer Drugs Market

4. Global Prostate Cancer Incidence

5. Global Prostate Cancer Drugs Market Share

6. Global Prostate Cancer – Hormonal Therapy Drugs Sales & Forecast to 2020
6.1 Luteinizing Hormone – Releasing Hormone (LHRH) Antagonists
6.1.1 Zytiga
6.1.2 Gonax / Firmagon
6.2 Luteinizing Hormone – Releasing Hormone (LHRH) Analogs
6.2.1 Lupron
6.2.2 Zoladex
6.2.3 Decapeptyl
6.2.4 Eligard
6.2.5 Vantas
6.2.6 Leuplin
6.3 Anti – Androgens
6.3.1 Casodex
6.3.2 Xtandi or MDV3100
6.3.3 Xtandi US or MDV3100

7. Global Prostate Cancer – Chemotherapy Drugs Market
7.1 Taxotere
7.2 Jevtana

8. Global Prostate Cancer – Immunotherapy Drugs Market
8.1 Provenge

9. Global Prostate Cancer – Targeted Therapy Drugs Market
9.1 Xofigo or Alpharadin

10. Global Prostate Cancer Market – Driving Factors
10.1 Introduction of Innovative Drugs
10.2 Advancement in Oncology Therapeutic Area
10.3 Development in Genomics & Proteomics

11. Global Prostate Cancer Market – Challenges
11.1 Costly Prostate Cancer Drugs
11.2 Adverse Events of Treatment
11.3 Low Success Rate for Oncology Drugs

List of Tables:

Table 5–1: Global – Prostate Cancer Drugs Market Share (Percent), 2011 – 2014
Table 5–2: Global – Forecast for Prostate Cancer Drugs Market Share (Percent), 2015 – 2020

List of Figures:

Figure 3–1: Global – Prostate Cancer Drugs Market (Million US$), 2010 – 2014
Figure 3–2: Global – Forecast for Prostate Cancer Drugs Market (Million US$), 2015 – 2020
Figure 4–1: Global – Prostate Cancer Incidence (Number), 2007 – 2014
Figure 4–2: Global – Forecast for Prostate Cancer Incidence (Number), 2015 – 2020
Figure 6–1: Global – Zytiga Drugs Sales (Million US$), 2011 – 2014
Figure 6–2: Global – Forecast for Zytiga Drugs Sales (Million US$), 2015 – 2020
Figure 6–3: Global – Gonax/ Firmagon Drugs Sales (Million US$), 2012 – 2014
Figure 6–4: Global – Forecast for Gonax Drugs Sales (Million US$), 2015 – 2020
Figure 6–5: Global – Lupron Drugs Sales (Million US$), 2009 – 2014
Figure 6–6: Global – Forecast for Lupron Drugs Sales (Million US$), 2015 – 2020
Figure 6–7: Global – Zoladex Drugs Sales (Million US$), 2009 – 2014
Figure 6–8: Global – Forecast for Zoladex Drugs Sales (Million US$), 2015 – 2020
Figure 6–9: Global – Decapeptyl Drugs Sales (Million US$), 2009 – 2014
Figure 6–10: Global – Forecast for Decapeptyl Drugs Sales (Million US$), 2015 – 2020
Figure 6–11: Global – Eligard Drug Sales (Million US$), 2009 – 2014
Figure 6–12: Global – Forecast for Eligard Drug Sales (Million US$), 2015 – 2020
Figure 6–13: Global – Vantas Drugs Sales (Million US$), 2009 – 2014
Figure 6–14: Global – Forecast for Vantas Drugs Sales (Million US$), 2015 – 2020
Figure 6–15: Global – Leuplin Drugs Sales (Million US$), 2009 – 2014
Figure 6–16: Global – Forecast for Leuplin Drugs Sales (Million US$), 2015 – 2020
Figure 6–17: Global – Casodex Drug Sales (Million US$), 2009 – 2014
Figure 6–18: Global – Forecast for Casodex Drug Sales (Million US$), 2015 – 2020
Figure 6–19: Global – Xtandi or MDV3100 Drug Sales (Million US$), 2012 – 2014
Figure 6–20: Global – Forecast for Xtandi or MDV3100 Drug Sales (Million US$), 2015 – 2020
Figure 6–21: Global – Xtandi US or MDV3100 Drug Sales (Million US$), 2012 – 2014
Figure 6–22: Global – Forecast for Xtandi US or MDV3100 Drug Sales (Million US$), 2015 – 2020
Figure 7–1: Global – Taxotere Drug Sales (Million US$), 2011 – 2014
Figure 7–2: Global – Forecast for Taxotere Drug Sales (Million US$), 2015 – 2020
Figure 7–3: Global – Jevtana Drug Sales (Million US$), 2010 – 2014
Figure 7–4: Global – Forecast for Jevtana Drug Sales (Million US$), 2015 – 2020
Figure 8–1: Global – Provenge Drugs Sales (Million US$), 2011 – 2014
Figure 8–2: Global – Forecast for Provenge Drugs Sales (Million US$), 2015 – 2020
Figure 9–1: Global – Xofigo or Alpharadin Drug Sales (Million US$), 2013 – 2014
Figure 9–2: Global – Forecast for Xofigo or Alpharadin Drug Sales (Million US$), 2015 – 2020
Figure 11–1: Therapeutic Categories – Overall Success Rate from Phase 1 through Likelihood of Approval (Percent), 2004 – 2010

  • Global Cancer Immunomodulator Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......
  • Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......
  • Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......
  • Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125
    According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......
  • Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......
  • Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......
  • T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85
    CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......
  • Global Kaposi Sarcoma Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107
    Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......
  • Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs